U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
157861157861ProAlgaZyme Novel Algae Infusion: Applications in ImmunodeficiencyCompletedNo Results AvailableHIV Infections|Hepatitis B|DyslipidemiaDrug: ProAlgaZymehttps://ClinicalTrials.gov/show/NCT00493506
157862157862Pore Excision, Curettage, and Injection of Cymetra for Pilonidal DiseaseRecruitingNo Results AvailablePilonidal SinusProcedure: surgery (Pore Excision, Curettage, and Injection of Cymetra)https://ClinicalTrials.gov/show/NCT00493493
157863157863Danish Carvedilol Study in Portal HypertensionCompletedNo Results AvailableCirrhosis|Portal HypertensionDrug: carvedilol|Drug: propranololhttps://ClinicalTrials.gov/show/NCT00493480
157864157864Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent LymphomasCompletedNo Results AvailableLymphomaDrug: Ibritumomab Tiuxetan (Zevalin)|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00493467
157865157865Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent LymphomasTerminatedHas ResultsLymphomaDrug: Zevalin|Drug: Rituximab|Drug: ^111 In Ibritumomab Tiuxetanhttps://ClinicalTrials.gov/show/NCT00493454
157866157866AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic CancerTerminatedNo Results AvailablePancreatic CancerDrug: AVN944https://ClinicalTrials.gov/show/NCT00493441
157867157867Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot StudyWithdrawnNo Results AvailableHepatocellular CarcinomaDrug: Baclofenhttps://ClinicalTrials.gov/show/NCT00493428
157868157868The Effect of Nitroglycerine on Microcirculatory Abnormalities During SepsisCompletedNo Results AvailableSepsis|Septic ShockDrug: nitroglycerin iv|Drug: placebo = nacl 0.9%https://ClinicalTrials.gov/show/NCT00493415
157869157869Different Regimens of Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaProcedure: Transarterial chemoembolization (TACE)|Procedure: Transarterial chemoembolization (TACE)|Procedure: Transarterial chemoembolization (TACE)https://ClinicalTrials.gov/show/NCT00493402
157870157870Cortisol Response to Adrenocorticotrophin (ACTH) in Acute StressRecruitingNo Results AvailableAortic Aneurysm, AbdominalDrug: Adrenocorticotrophic hormonehttps://ClinicalTrials.gov/show/NCT00493389
157871157871Study of Tumour Response to Tirapazamine During Treatment of Cervical CancerTerminatedNo Results AvailableCervix CancerProcedure: Cervical tissue biopsy analysis: Comet assay|Procedure: Biopsy: Measurement of histone gamma H2AX phosphorylation|Procedure: Biopsy: Immunohistochemistry: Ca9, Glut1, HIF-1 alpha|Procedure: Measurement of vascular perfusion: contrast enhanced MRIhttps://ClinicalTrials.gov/show/NCT00493376
157872157872Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western CambodiaCompletedNo Results AvailableFalciparum MalariaDrug: artesunate 2 mg/kg/day versus 4 mg/kg/day icm mefloquinehttps://ClinicalTrials.gov/show/NCT00493363
157873157873Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast CancerCompletedNo Results AvailableBreast CancerProcedure: Blood Samplehttps://ClinicalTrials.gov/show/NCT00493350
157874157874A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering TreatmentCompletedNo Results AvailableHypercholesterolemiaBehavioral: advanced adherence counseling+reminder|Device: Compliance Cardhttps://ClinicalTrials.gov/show/NCT00493337
157875157875Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisCompletedNo Results AvailableChronic Plaque PsoriasisDrug: alefacept|Drug: polyvalent pneumococcal vaccinehttps://ClinicalTrials.gov/show/NCT00493324
157876157876Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult MalesCompletedHas ResultsFeverDrug: IV Placebo|Drug: IV Acetaminophen|Biological: Reference Standard Endotoxin (RSE)https://ClinicalTrials.gov/show/NCT00493311
157877157877Tysabri Observational ProgramRecruitingNo Results AvailableRelapsing-Remitting Multiple SclerosisDrug: natalizumabhttps://ClinicalTrials.gov/show/NCT00493298
157878157878Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to - CompletedHas ResultsRespiratory Viral Infections|Respiratory Syncytial Virus Infections|Parainfluenza Virus 3, HumanBiological: MEDI-534|Biological: MEDI-534|Biological: MEDI-534https://ClinicalTrials.gov/show/NCT00493285
157879157879Dilutional Coagulopathy in Patients Undergoing Elective SurgeryCompletedNo Results AvailableBlood Coagulation DisorderDrug: Fibrinogenhttps://ClinicalTrials.gov/show/NCT00493272
157880157880Health Related QOL, Depression and Lifestyle Changes in Insulin Resistant AdolescentsRecruitingNo Results AvailableInsulin Resistance|DepressionBehavioral: Health-Related Quality of Life instrument|Behavioral: Depression Scale for Children (CES-DC)https://ClinicalTrials.gov/show/NCT00493259
157881157881Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric InpatientsCompletedHas ResultsPain|FeverDrug: IV Acetaminophen|Drug: IV Acetaminophenhttps://ClinicalTrials.gov/show/NCT00493246
157882157882Antipsychotic Polypharmacy in SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: 2 antipsychotic medications (combinations of olanzapine, risperidone, clozapine, seroquel, haldol, perphenazine)|Drug: main antipsychotic medication and placebohttps://ClinicalTrials.gov/show/NCT00493233
157883157883Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone AdministrationCompletedHas ResultsHealthyDrug: SC HYLENEX and Ceftriaxone|Drug: SC Placebo and Ceftriaxone|Drug: IV Ceftriaxonehttps://ClinicalTrials.gov/show/NCT00493220
157884157884Fibrosis in Renal AllograftsRecruitingNo Results AvailableKidney Failure, Chronic|Transplantation|Immunosuppression|Interstitial FibrosisDrug: sirolimus|Drug: cyclosporine|Drug: daclizumabhttps://ClinicalTrials.gov/show/NCT00493194
157885157885Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) PatientsCompletedHas ResultsLeukemia|Chronic Myelogenous Leukemia|Chronic Myeloid LeukemiaDrug: Interleukin-11 (IL-11 or Neumega)https://ClinicalTrials.gov/show/NCT00493181
157886157886Determination of the Prevalence and Prognostic Importance of Unrecognized Non-Q-wave Myocardial Infarction by MRICompletedNo Results AvailableCoronary Arteriosclerosis|Myocardial Infarctionhttps://ClinicalTrials.gov/show/NCT00493168
157887157887A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.CompletedNo Results AvailableNeoplasmsDrug: RG1530https://ClinicalTrials.gov/show/NCT00493155
157888157888Pre-operative Rehabilitation Exercise Program for Total Knee ArthroplastyActive, not recruitingNo Results AvailableOsteoarthritis|Rheumatoid ArthritisBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT00493142
157889157889Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)CompletedNo Results AvailableLeukemia|Systemic MastocytosisDrug: Ontak (Denileukin Diftitox)https://ClinicalTrials.gov/show/NCT00493129
157890157890Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon BetaCompletedNo Results AvailableRelapsing-Remitting Multiple SclerosisDrug: Interferon-beta-1a|Drug: methylprednisolonehttps://ClinicalTrials.gov/show/NCT00493116

* Görseller ve İçerik tekif hakkına sahip olabilir